Abstract
Migraine is considered one of the most important causes of disease-related disability worldwide, contributing to functional disorders as well as significant social and economic burden [1]. Although there are several medications used to treat migraine patients, many such patients either cannot tolerate the side effects or do not respond to oral migraine prevention medications. Up to 78 % of migraine patients are known to experience treatment failure [2,3].
Publisher
PANORAMA Publishing House
Subject
General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine,Ocean Engineering,General Medicine,General Medicine,General Medicine,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine
Reference47 articles.
1. Migraine;McGregor;Ann Intern Med 166 (7),2017
2. Side effects associated with current and prospective antimigraine pharmacotherapies;González-Hernández;Expert Opin Drug Metab Toxicol 14 (1),2018
3. A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns;Ford;Headache 57 (10),2017
4. 4. Zhurnal nevrologii i psikhiatrii im. Korsakova [Journal of Neurology and Psychiatry named after S. S. Korsakov]. Special issues, № 1, 2022,5. (In Russ.)
5. The International Classification of Headache Disorders, 3rd edition (ICHD-3);5;Cephalalgia,2018